Abstract
Penbutolol and propranolol were administered orally in a dosage of 40 mg once daily and 80 mg twice daily, respectively to 12 patients with hypertension and impaired renal function. Both drugs caused a significant decrease in mean arterial pressure and heart rate. Serum creatinine concentration increased significantly by 10% during therapy with propranolol without concomitant decrease in creatinine clearance. No such effect was seen with penbutolol. GFR measured with [125I]-iothalamate showed no significant changes with both drugs.
Full text
PDF





Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bauer J. H. Effects of propranolol therapy on renal function and body fluid composition. Arch Intern Med. 1983 May;143(5):927–931. [PubMed] [Google Scholar]
- Bernard N., Cuisinaud G., Sassard J. Determination of penbutolol and its hydroxylated metabolite in biological fluids by reversed-phase high-performance liquid chromatography. J Chromatogr. 1982 Mar 12;228:355–361. doi: 10.1016/s0378-4347(00)80454-5. [DOI] [PubMed] [Google Scholar]
- Danesh B. J., Brunton J., Sumner D. J. Comparison between short-term renal haemodynamic effects of propranolol and nadolol in essential hypertension: a cross-over study. Clin Sci (Lond) 1984 Aug;67(2):243–248. doi: 10.1042/cs0670243. [DOI] [PubMed] [Google Scholar]
- Donker A. J., van der Hem G. K., Sluiter W. J., Beekhuis H. A radioisotope method for simultaneous determination of the glomerular filtration rate and the effective renal plasma flow. Neth J Med. 1977;20(3):97–103. [PubMed] [Google Scholar]
- Freiman J. A., Chalmers T. C., Smith H., Jr, Kuebler R. R. The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials. N Engl J Med. 1978 Sep 28;299(13):690–694. doi: 10.1056/NEJM197809282991304. [DOI] [PubMed] [Google Scholar]
- Gunnells J. C., Jr, Bath N. M., Sode J., Robinson R. R. Prinary aldosteronism. Arch Intern Med. 1967 Nov;120(5):568–574. [PubMed] [Google Scholar]
- Ibsen H., Sederberg-Olsen P. Changes in glomerular filtration rate during long-term treatment with propranolol in patients with arterial hypertension. Clin Sci. 1973 Feb;44(2):129–134. doi: 10.1042/cs0440129. [DOI] [PubMed] [Google Scholar]
- Ito T., Woo J., Haning R., Horton R. A radioimmunoassay for aldosterone in human peripheral plasma including a comparison of alternate techniques. J Clin Endocrinol Metab. 1972 Jan;34(1):106–112. doi: 10.1210/jcem-34-1-106. [DOI] [PubMed] [Google Scholar]
- Jatlow P., Bush W., Hochster H. Improved liquid-chromatographic determination of propranolol in plasma, with fluorescence detection. Clin Chem. 1979 May;25(5):777–779. [PubMed] [Google Scholar]
- Meyer B. H., Müller F. O., Lötter M. G., Iturralde M. P., Grigoleit H. G. The effect of penbutolol on glomerular filtration. S Afr Med J. 1981 Aug 8;60(6):243–244. [PubMed] [Google Scholar]
- Shemesh O., Golbetz H., Kriss J. P., Myers B. D. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int. 1985 Nov;28(5):830–838. doi: 10.1038/ki.1985.205. [DOI] [PubMed] [Google Scholar]
- Swainson C. P., Winney R. J. Letter: Effect of beta-blockade in chronic renal failure. Br Med J. 1976 Feb 21;1(6007):459–459. doi: 10.1136/bmj.1.6007.459-c. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Thompson F. D., Joekes A. M. Letter: Beta-blockade in the presence of renal disease and hypertension. Br Med J. 1974 Jun 8;2(5918):555–556. doi: 10.1136/bmj.2.5918.555-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Warren D. J., Swainson C. P., Wright N. Deterioration in renal function after beta-blockade in patients with chronic renal failure and hypertension. Br Med J. 1974 Apr 27;2(5912):193–194. doi: 10.1136/bmj.2.5912.193. [DOI] [PMC free article] [PubMed] [Google Scholar]
